“astellas” Archives

in
Entry Author Date Location
Bayer Boosts Women’s Health Drug Pipeline, Paying $425M for KaNDy 08/11/20 Europe
Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential 02/12/20 San Diego
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
BeiGene Puts Up $10M to Use Ambrx’s Drug Development Technology 03/07/19 San Diego
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More 02/16/18 National
Astellas Buys Stem Cell Gene-Editing Firm Universal Cells for $102.5M 02/14/18 Seattle
Starting a Medtech Company? Try Skipping Venture Capital, VCs Say 02/14/17 Texas
Amylyx Nabs $5M to Take Aim at Nerve Cell Death in ALS Patients 08/22/16 Boston
Cytokinetics Gets $95M in First ALS Deal, Needs Results For More 07/27/16 San Francisco
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
San Diego’s Ambrx Working with Astellas to Develop Anti-Cancer Drugs 04/08/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More 04/04/13 San Diego
Optimer Shares Soar Amid Reports of Buyout Interest 04/02/13 San Diego
Page 1 of 1